DJIA 16,461.32 -153.49 -0.92%
NASDAQ 4,382.85 -36.63 -0.83%
S&P 500 1,927.11 -14.17 -0.73%
market minute promo

NxStage Medical (NASDAQ: NXTM)

14.48 0.08 (0.56%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NXTM $14.48 0.56%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.41
Previous Close $14.40
Daily Range $14.23 - $14.50
52-Week Range $8.77 - $15.50
Market Cap $895.2M
P/E Ratio -45.00
Dividend (Yield) $0.00 (0.0%)
Volume 299,783
Average Daily Volume 270,627
Current FY EPS -$0.44




Healthcare Information Services

NxStage Medical (NXTM) Description

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Website:

News & Commentary

Is It Time to Buy These 4 Dialysis Stocks?

Should you consider buying these four dialysis stocks -- DaVita, Fresenius, NxStage, and Rockwell -- since the Centers for Medicare and Medicaid Services changed its tune on reducing payments to kidney dialysis providers?

Commit To Purchase NxStage Medical At $12.50, Earn 14.1% Annualized Using Options

Lumenis: Shares In This Medical Device Maker Are Poised For Gains

Update: NxStage Medical Earnings

NxStage Medical's (NXTM) CEO Jeff Burbank on Q2 2014 Results - Earnings Call Transcript

Sector Update: Health Care

Sector Update: Health-Care Shares Higher Pre-Market

NxStage Medical (NXTM) Q2 2014 Results - Earnings Call Webcast

Mariel Therapeutics Acquires Stryker Assets - Analyst Blog

St. Jude Medical Hits New Lifetime High - Analyst Blog

Medtronic's MiniMed Insulin Pump: A Key to Type 2 Diabetes Cure - Analyst Blog

See More NXTM News...

NXTM's Top Competitors

NXTM $14.48 (0.56%)
Current stock: NXTM
$0.00 (0.00%)
Current stock:
MDT $64.66 (-0.49%)
Current stock: MDT
COV $87.41 (-2.06%)
Current stock: COV